thumbnail image
  • SCIENCE
  • CLINICAL TRIALS
  • PARTNERS 
    • PHARMA
    • PAYORS
    • HEALTH SYSTEMS
  • NEWS
  • OUR COMPANY 
    • AmDTx
    • OUR TEAM
    • CAREERS
  • CONTACT US
  • …  
    • SCIENCE
    • CLINICAL TRIALS
    • PARTNERS 
      • PHARMA
      • PAYORS
      • HEALTH SYSTEMS
    • NEWS
    • OUR COMPANY 
      • AmDTx
      • OUR TEAM
      • CAREERS
    • CONTACT US
    • SCIENCE
    • CLINICAL TRIALS
    • PARTNERS 
      • PHARMA
      • PAYORS
      • HEALTH SYSTEMS
    • NEWS
    • OUR COMPANY 
      • AmDTx
      • OUR TEAM
      • CAREERS
    • CONTACT US
    • …  
      • SCIENCE
      • CLINICAL TRIALS
      • PARTNERS 
        • PHARMA
        • PAYORS
        • HEALTH SYSTEMS
      • NEWS
      • OUR COMPANY 
        • AmDTx
        • OUR TEAM
        • CAREERS
      • CONTACT US
      • SCIENCE
      • CLINICAL TRIALS
      • PARTNERS
        • PHARMA
        • PAYORS
        • HEALTH SYSTEMS
      • NEWS
      • OUR COMPANY
        • AmDTx
        • OUR TEAM
          • OUR TEAM
          • CHIEF EXECUTIVE OFFICER
          • CHIEF TECHNOLOGY OFFICER
          • CHIEF OF CONTENT
          • CHIEF FINANCIAL OFFICER
          • VP PHARMACEUTICALS
          • ASSISTANT TO THE CEO
        • CAREERS
      • CONTACT US
        Go Back

        Dr. Joseph Mocanu

        "Consistent and persistent is the goal."
        LinkedIn
        LinkedIn
        More Details

        I am the founder and Managing Partner of Verge HealthTech Fund, the world's first seed stage health tech VC investing in healthcare technology solutions relevant to emerging Asia. Prior to this, I was a scientist researching new cancer therapies, a medical device entrepreneur, and a management consultant for Oliver Wyman, where I led life sciences and digital health across Asia. I have 19 scientific publications, 3 patents and have made investments in 18 healthcare technology companies to date.

        I have a PhD from the University of Toronto and an MBA from the Richard Ivey School of Business.

        • To prevent, measure, and treat mental illness, we develop digital theragnostics personalised with objective and scalable biomarkers.

          ↓↓↓
        • Proprietary Technology

          Our software uses facial photoplethysmography (PPG) and deep neural networks to personalise safe and effective treatments, while providing real time data on real world efficacy. The resulting gamified "measure-treat-measure" system has been clinically proven to reduce the risk of mental illness in cancer patients, as well as alleviate anxiety in young adults when compared to placebo in multiple clinical trials.

          Learn More
        • AI-based theragnostics every patient can access.

          Digitally-enabled pharmacotherapy, theragnostics and mental health endpoints.

          Pharma

          Giving policyholders access to clinically-validated mental wellness tools.

          Payors

          Supporting personalised healthcare on site and at home.

           

          Health Systems
        • Subscribe to the newsletter.

          Monthly updates on our progress tackling the world's mental health crisis.

          Subscribe

        CONTACT US

        TERMS OF USE

        PRIVACY POLICY

        Effective and accessible healthcare for every human.

          All Posts
          ×
          Cookie Use
          We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
          Learn More